Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
12 Jun to 12 Jul 2002
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2002
Report date:
2002

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
(1997)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Dimethoxydiphenylsilane
EC Number:
229-929-1
EC Name:
Dimethoxydiphenylsilane
Cas Number:
6843-66-9
Molecular formula:
C14H16O2Si
IUPAC Name:
dimethoxydiphenylsilane
Details on test material:
- Name of test material (as cited in study report): Dimethoxy diphenylsilane
- Physical state: clear colourless liquid
- Lot/batch No.: C42008
- Storage condition of test material: room temperature over silica gel, in darkness under nitrogen
- Date of delivery: 2002-04-02

Method

Target gene:
HIS operon (S. typhimurium), TRP operon (E. coli)
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
S9 mix from phenobarbitone/ß-naphthoflavone induced male Sprague-Dawley rats
Test concentrations with justification for top dose:
- Range-finding study (cytotoxicity): 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500, and 5000 µg/plate
- Range-finding study: 50, 150, 500, 1500, and 5000 µg/plate
- Main study: 50, 150, 500, 1500, and 5000 µg/plate
- Confirmatory study: 500, 1000, 1500, 3000, and 5000 µg/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO (prior to experiment dried over molecular sieves (sodium alumino-silicate) ie 2 mm pellets with a nominal pore diameter of 4 x 10 E-4 microns)
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
N-ethyl-N-nitro-N-nitrosoguanidine
Remarks:
without metabolic activation Migrated to IUCLID6: 2 mg/plate for WP2uvrA-, 3 µg/plate for TA100, and 5 µg/plate for TA1535
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
Remarks:
without metabolic activation Migrated to IUCLID6: 50 µg/plate for TA1537
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
Remarks:
without metabolic activation Migrated to IUCLID6: 0.2 µg/plate for TA98
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 2-aminoanthracene 1µg/plate for TA100, 2 µg/plate for TA 1535 and TA 1537, 10 µg/plate for WP2 uvrA-
Remarks:
with metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
benzo(a)pyrene
Remarks:
with metabolic activation Migrated to IUCLID6: 5 µg/plate for TA98
Details on test system and experimental conditions:
METHOD OF APPLICATION
- Range-finding study: in agar (plate incorporation)
- Main study: in agar (plate incorporation)
- Confirmatory study: in agar (plate incorporation) and preincubation

DURATION
- Preincubation period: 20 min
- Exposure duration: 48 hours

NUMBER OF REPLICATIONS: 3 independent experiments were carried out
- Range-finding study: 3 plates
- Main study: 3 plates
- Confirmatory study: 5 plates (only TA1535 without metabolic activation)

DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency (preliminary study, only with TA100 and WP2uvrA-)
Evaluation criteria:
The test material may be considered positive in this test system if it has induced a reproducible, dose-related and statistically significant increase in the revertant count in at least one strain of bacteria.
Statistics:
Dunnet's method of linear regression

Results and discussion

Test resultsopen allclose all
Species / strain:
other: S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2 uvrA
Metabolic activation:
with
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Species / strain:
bacteria, other: TA 1537, TA 98, TA 100, WP2 uvrA-
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
without
Genotoxicity:
positive
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- none

Any other information on results incl. tables

Tab. 1: Test results from the range-finding study.

Test material

TA 100

TA 1535

WP2 uvrA

TA 98

TA 1537

+ S9

- S9

+ S9

- S9

+ S9

- S9

+ S9

- S9

+ S9

- S9

Solvent control

104 ± 5.2

110 ± 10.1

22 ± 6.1

23 ± 2.1

23 ± 3.8

24 ± 11.1

33 ± 8.3

23 ± 1.7

25 ± 6.1

18 ± 3.1

Test item

50 µg/plate

106 ± 13.0

93 ± 4.4

22 ± 4.6

33 ± 6.6

24 ± 0.6

20 ± 1.7

36 ± 4.7

19 ± 3.5

31 ± 1.7

18 ± 5.0

150 µg/plate

102 ± 7.2

86 ± 15.9

18 ± 3.8

40 ± 7.9

24 ± 3.2

26 ± 5.7

35± 1.5

22 ± 2.6

25 ± 8.3

20 ± 2.5

500 µg/plate

97 ± 8.0

112 ± 2.9

18 ± 2.9

51 ± 6.7**

24 ± 3.8

17 ± 0.6

37 ± 3.6

20 ± 3.5

20 ± 3.5

17 ± 0.6

1500 µg/plate

80 ± 15.5

104 ± 14.8

15 ± 3.5

60 ± 11.5***

16 ± 4.0

14 ± 4.9

37 ± 3.0

17 ± 1.2

23 ± 1.7

19 ± 2.1

5000 µg/plate

82 ± 6.4

97 ± 13.6

13± 2.9

51 ± 18.2**

15 ± 4.7

17 ± 3.5

32 ± 9.5

21 ± 2.1

19 ± 4.6

14 ± 3.2

Positive control

2388 ± 68.8

395 ± 300.8

215 ± 9.2

603 ± 75.0

1213 ± 26.3

765 ± 30.4

228 ± 0.6

158 ± 8.4

292 ± 47.4

2091 ± 232.8

** p 0.01        *** p 0.005

Tab. 2: Test results from the main study

Test material

TA 100

TA 1535

WP2 uvrA

TA 98

TA 1537

+ S9

- S9

+ S9

- S9

+ S9

- S9

+ S9

- S9

+ S9

- S9

Solvent control

89 ± 5.0

86 ± 13.3

15 ± 3.5

28 ± 3.8

20 ± 3.6

18 ± 3.6

38 ± 3.6

21 ± 7.5

17 ± 4.0

9 ± 4.5

Test item

50 µg/plate

96 ± 11.0

93 ± 16.4

15 ± 2.5

30 ± 6.7

24 ± 1.2

23 ± 3.6

34 ± 5.3

15 ± 2.6

18 ± 4.5

6 ± 1.0

150 µg/plate

87 ± 5.0

96 ± 16.5

14 ± 1.2

38 ± 9.6

21 ± 5.5

26 ± 6.9

33 ± 6.0

17 ± 5.2

19 ± 3.6

7 ± 1.5

500 µg/plate

103 ± 11.4

111 ± 10.1

19 ± 1.2

51 ± 3.5***

26 ± 6.4

21 ± 9.3

42 ± 6.2

20 ± 1.5

18 ± 2.5

9 ± 2.5

1500 µg/plate

76 ± 15.0

113 ± 6.0

16 ± 2.0

43 ± 3.8*

20 ± 2.3

16 ± 3.6

43 ± 9.3

15 ± 7.0

19 ± 4.0

13± 4.0

5000 µg/plate

59 ± 6.2

92 ± 13.6

10 ± 2.6

41 ± 3.6*

17 ± 1.5

8 ± 3.2

37 ± 10.4

12 ± 3.0

19 ± 1.7

3 ± 1.0

Positive control

1963 ± 315.0

378 ± 99.3

174 ± 26.9

282 ± 7.2

610 ± 116.8

918 ± 18.9

129 ± 21.0

114 ± 9.5

328 ± 17.4

2200 ± 122.0

* p 0.05           *** p 0.005

Tab. 3: Test results from the confirmatory study

 

Test material

TA 1535

Preincubation Method

Plate incorporation Method

Solvent control

20 ± 3.0

21 ± 4.5

Test item

500 µg/plate

43 ± 9.8***

41 ± 9.4***

1000 µg/plate

48 ± 9.6***

44 ± 8.2***

1500 µg/plate

42 ± 7.7 ***

41 ± 5.8***

3000 µg/plate

54.6 ± 7.6***

52 ± 10.5***

5000 µg/plate

50 ± 6.3***

49 ± 8.3***

Positive control

667 ± 71.0

667 ± 71.0

*** p 0.005

Applicant's summary and conclusion

Conclusions:
Interpretation of results: positive without metabolic activation in TA 1535

Dimethoxydiphenysilane has been tested according to OECD 471 (1997) and in compliance with GLP in Salmonella typhimurium strains TA 98, TA 100, TA 1535 and TA 1537, as well as in Escheria coli WP2uvrA-. No increase in revertants was detected at any concentration up to the limit concentration, with metabolic activation in the plate incorporation test. In addition, no mutagenicity was observed in TA 98, TA 100, TA 1537, and WP2uvrA- in the absence of an metabolic activation system. In contrast, TA 1535 showed statistically significant increases of revertants in both the range-finding study and in the main study. A confirmatory experiment testing this strain in the plate incorporation assay and in the pre-incubation assay without metabolic activation revealed similar results. Appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is positive for mutagenicity to bacteria under the conditions of the test.